The Bulgarian Prime Minister announced on Friday the suspension of injections of AstraZeneca’s anti-Covid vaccine, in the wake of similar decisions by Denmark, Iceland and Norway in the face of serious cases of blood clots. “I order a cessation of vaccinations with AstraZeneca until the European Medicines Agency (EMA) dispels any doubt as to its safety,” said Boïko Borissov, quoted in a statement, asking for “written” proof of from the European regulator.
According to him, the EMA did not formulate a “clear diagnosis”. She estimated Thursday that European countries could continue to use the vaccine developed by the British laboratory AstraZeneca and the University of Oxford. The position of the safety committee “is that the benefits of the vaccine continue to outweigh its risks and that the vaccine can continue to be administered while the investigation of cases of thromboembolism is ongoing,” the EMA wrote. in a press release.
Bulgaria lagging behind
“There is currently no indication that the vaccination caused these conditions, which are not listed as side effects of this vaccine.” Denmark, Norway and Iceland temporarily suspended the deployment of AstraZeneca’s Covid-19 vaccine on Thursday, over concerns about patients who developed blood clots after being vaccinated. Other countries, like Austria, Italy or Romania, have for their part suspended the deployment of specific batches, while Thailand suddenly delayed the launch of its vaccination campaign.
This decision by the Bulgarian government comes as Bulgaria lags behind the EU with just 270,000 people who have received a dose, or 3.9% of the population. Until now, the AstraZeneca vaccine has been administered to the general population without restrictions. “No adverse effects other than those described by the manufacturer in the leaflet have been reported,” said the health authorities of the country. The campaign continues for now with the other two vaccines available, Pfizer-BioNTech and Moderna, they added.